{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/152452986"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Current OMH quality goals include decreasing polypharmacy (the use of multiple medications), decreasing unnecessary use of medications with a high risk of causing weight gain, pre-diabetes (called insulin insensitivity) and diabetes, heart disease and hypertension, and high cholesterol and other lipids." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "ny.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/413856070"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/152452986" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/358068901"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/152452986"] } } }
